InnovAge Holdings, Inc. INNV Increase (decrease) in cash, cash equivalents, and restricted cash

Increase (decrease) in cash, cash equivalents, and restricted cash at other companies

WhirlpoolWHR

-$44M+82.5%

SPS CommerceSPSC

$2.92M+102%

ScansourceSCSC

-$41.46M-20.1%

Construction PartnersROAD

-$27.21M—

AbCellera Biologics Inc.ABCL

-$51.45M-1,849%

Skyline ChampionSKY

$41.02M+256%

Other financials

Income statement

See full

Revenue$251.9M+15.5%

Operating income-$29.1M-186%

Net income-$29.5M-159%

EPS (diluted)-$0.22-175%

Balance sheet

See full

Cash & equivalents$95.5M+58.0%

Total debt$93.8M-11.0%

Total equity$229.0M-3.8%

Total assets$547.4M+2.0%

Cash flow

See full

Operating cash flow$18.1M-26.3%

CapEx$3.6M+24.3%

Free cash flow$14.5M-33.1%

Valuation

See full

Market cap$1.4B+167%

Enterprise value$1.4B+146%

P/S1.5×+0.8×

Profitability

See full

Operating margin-1%-0.4pp

Net margin-1.2%-0.5pp

FCF margin4.5%+2.6pp

Returns & leverage

See full

Return on equity-5%-1.8pp

Debt / equity0.4×0.0×

Current ratio1×+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations.

The official record: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InnovAge Holdings, Inc.'s increase (decrease) in cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is InnovAge Holdings, Inc.'s increase (decrease) in cash, cash equivalents, and restricted cash?: InnovAge Holdings, Inc. (INNV) reported increase (decrease) in cash, cash equivalents, and restricted cash of $12.33M in Q1 2026.
How has InnovAge Holdings, Inc.'s increase (decrease) in cash, cash equivalents, and restricted cash changed year-over-year?: InnovAge Holdings, Inc.'s increase (decrease) in cash, cash equivalents, and restricted cash decreased by 14.2% year-over-year, from $14.38M to $12.33M.